2-肼苯并咪唑衍生腙的合成、分子表征及抗菌评价。

IF 5.1 2区 医学 Q1 CHEMISTRY, MEDICINAL
Drug Design, Development and Therapy Pub Date : 2025-05-27 eCollection Date: 2025-01-01 DOI:10.2147/DDDT.S521541
Muneera S M Al-Saleem, Mohamed S Mohamed Ahmed, Sayed M Riyadh, Awatif H Alruwaili, Magdi E A Zaki, Sobhi M Gomha
{"title":"2-肼苯并咪唑衍生腙的合成、分子表征及抗菌评价。","authors":"Muneera S M Al-Saleem, Mohamed S Mohamed Ahmed, Sayed M Riyadh, Awatif H Alruwaili, Magdi E A Zaki, Sobhi M Gomha","doi":"10.2147/DDDT.S521541","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Hydrazones, due to the structural diversity of their nitrogen atoms, possess both electrophilic and nucleophilic properties, enabling strong hydrogen bonding interactions with enzymes and receptors. This study aimed to synthesize novel hydrazone derivatives and evaluate their antimicrobial potential.</p><p><strong>Methods: </strong>Hydrazones were synthesized via condensation of 2-hydrazinobenzimidazole with various aldehydes or ketones using citric acid as an eco-friendly catalyst. The (E)-configuration of the products was confirmed through frontier molecular orbital (FMO) calculations. Antimicrobial activities were assessed against selected Gram-positive and Gram-negative bacteria, and fungi. Molecular docking studies were conducted on the most active compounds (<b>3c</b> and <b>3o</b>) using bacterial and fungal protein targets (2IWC, 2NXW, 1EA1).</p><p><strong>Results: </strong>Compounds <b>3c</b> and <b>3o</b> showed strong antimicrobial activity. Docking studies revealed that both compounds interacted with 2IWC via one H-bond donor to THR531 (3.12 Å), mirroring ampicillin. Against 2NXW, they showed dual H-donor bonding to MET404 with binding energies of -5.96 and -5.72 kcal/mol, comparable to gentamicin. Both also bound ARG326 in 1EA1 with binding energies of -5.97 and -6.0 kcal/mol, similar to nystatin.</p><p><strong>Discussion: </strong>The comparable binding patterns and energies of compounds <b>3c</b> and <b>3o</b> to standard antimicrobial agents suggest that they are promising candidates for further development as broad-spectrum antimicrobial agents.</p>","PeriodicalId":11290,"journal":{"name":"Drug Design, Development and Therapy","volume":"19 ","pages":"4437-4456"},"PeriodicalIF":5.1000,"publicationDate":"2025-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12126145/pdf/","citationCount":"0","resultStr":"{\"title\":\"Synthesis, Molecular Characterization, and Antimicrobial Evaluation of Hydrazones Derived from 2-Hydrazinobenzimidazole.\",\"authors\":\"Muneera S M Al-Saleem, Mohamed S Mohamed Ahmed, Sayed M Riyadh, Awatif H Alruwaili, Magdi E A Zaki, Sobhi M Gomha\",\"doi\":\"10.2147/DDDT.S521541\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Hydrazones, due to the structural diversity of their nitrogen atoms, possess both electrophilic and nucleophilic properties, enabling strong hydrogen bonding interactions with enzymes and receptors. This study aimed to synthesize novel hydrazone derivatives and evaluate their antimicrobial potential.</p><p><strong>Methods: </strong>Hydrazones were synthesized via condensation of 2-hydrazinobenzimidazole with various aldehydes or ketones using citric acid as an eco-friendly catalyst. The (E)-configuration of the products was confirmed through frontier molecular orbital (FMO) calculations. Antimicrobial activities were assessed against selected Gram-positive and Gram-negative bacteria, and fungi. Molecular docking studies were conducted on the most active compounds (<b>3c</b> and <b>3o</b>) using bacterial and fungal protein targets (2IWC, 2NXW, 1EA1).</p><p><strong>Results: </strong>Compounds <b>3c</b> and <b>3o</b> showed strong antimicrobial activity. Docking studies revealed that both compounds interacted with 2IWC via one H-bond donor to THR531 (3.12 Å), mirroring ampicillin. Against 2NXW, they showed dual H-donor bonding to MET404 with binding energies of -5.96 and -5.72 kcal/mol, comparable to gentamicin. Both also bound ARG326 in 1EA1 with binding energies of -5.97 and -6.0 kcal/mol, similar to nystatin.</p><p><strong>Discussion: </strong>The comparable binding patterns and energies of compounds <b>3c</b> and <b>3o</b> to standard antimicrobial agents suggest that they are promising candidates for further development as broad-spectrum antimicrobial agents.</p>\",\"PeriodicalId\":11290,\"journal\":{\"name\":\"Drug Design, Development and Therapy\",\"volume\":\"19 \",\"pages\":\"4437-4456\"},\"PeriodicalIF\":5.1000,\"publicationDate\":\"2025-05-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12126145/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Drug Design, Development and Therapy\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2147/DDDT.S521541\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Design, Development and Therapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/DDDT.S521541","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

摘要

由于氮原子结构的多样性,腙具有亲电性和亲核性,能够与酶和受体形成强氢键相互作用。本研究旨在合成新型腙衍生物并评价其抗菌潜力。方法:以柠檬酸为催化剂,通过2-肼苯并咪唑与多种醛或酮缩合反应合成腙。通过前沿分子轨道(FMO)计算确定了产物的(E)-构型。对选定的革兰氏阳性和革兰氏阴性细菌和真菌进行了抗菌活性评估。利用细菌和真菌蛋白靶点(2IWC, 2NXW, 1EA1)对活性最高的化合物(3c和30)进行分子对接研究。结果:化合物3c和30具有较强的抑菌活性。对接研究表明,这两种化合物都通过THR531 (3.12 Å)的一个氢键供体与2IWC相互作用,与氨苄西林相似。与2NXW相比,它们与MET404表现出双h供体键,结合能分别为-5.96和-5.72 kcal/mol,与庆大霉素相当。两者在1EA1中结合ARG326,结合能分别为-5.97和-6.0 kcal/mol,与制霉菌素相似。讨论:化合物3c和30与标准抗菌剂的结合模式和能量相似,表明它们是有希望进一步开发的广谱抗菌剂。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Synthesis, Molecular Characterization, and Antimicrobial Evaluation of Hydrazones Derived from 2-Hydrazinobenzimidazole.

Introduction: Hydrazones, due to the structural diversity of their nitrogen atoms, possess both electrophilic and nucleophilic properties, enabling strong hydrogen bonding interactions with enzymes and receptors. This study aimed to synthesize novel hydrazone derivatives and evaluate their antimicrobial potential.

Methods: Hydrazones were synthesized via condensation of 2-hydrazinobenzimidazole with various aldehydes or ketones using citric acid as an eco-friendly catalyst. The (E)-configuration of the products was confirmed through frontier molecular orbital (FMO) calculations. Antimicrobial activities were assessed against selected Gram-positive and Gram-negative bacteria, and fungi. Molecular docking studies were conducted on the most active compounds (3c and 3o) using bacterial and fungal protein targets (2IWC, 2NXW, 1EA1).

Results: Compounds 3c and 3o showed strong antimicrobial activity. Docking studies revealed that both compounds interacted with 2IWC via one H-bond donor to THR531 (3.12 Å), mirroring ampicillin. Against 2NXW, they showed dual H-donor bonding to MET404 with binding energies of -5.96 and -5.72 kcal/mol, comparable to gentamicin. Both also bound ARG326 in 1EA1 with binding energies of -5.97 and -6.0 kcal/mol, similar to nystatin.

Discussion: The comparable binding patterns and energies of compounds 3c and 3o to standard antimicrobial agents suggest that they are promising candidates for further development as broad-spectrum antimicrobial agents.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Drug Design, Development and Therapy
Drug Design, Development and Therapy CHEMISTRY, MEDICINAL-PHARMACOLOGY & PHARMACY
CiteScore
9.00
自引率
0.00%
发文量
382
审稿时长
>12 weeks
期刊介绍: Drug Design, Development and Therapy is an international, peer-reviewed, open access journal that spans the spectrum of drug design, discovery and development through to clinical applications. The journal is characterized by the rapid reporting of high-quality original research, reviews, expert opinions, commentary and clinical studies in all therapeutic areas. Specific topics covered by the journal include: Drug target identification and validation Phenotypic screening and target deconvolution Biochemical analyses of drug targets and their pathways New methods or relevant applications in molecular/drug design and computer-aided drug discovery* Design, synthesis, and biological evaluation of novel biologically active compounds (including diagnostics or chemical probes) Structural or molecular biological studies elucidating molecular recognition processes Fragment-based drug discovery Pharmaceutical/red biotechnology Isolation, structural characterization, (bio)synthesis, bioengineering and pharmacological evaluation of natural products** Distribution, pharmacokinetics and metabolic transformations of drugs or biologically active compounds in drug development Drug delivery and formulation (design and characterization of dosage forms, release mechanisms and in vivo testing) Preclinical development studies Translational animal models Mechanisms of action and signalling pathways Toxicology Gene therapy, cell therapy and immunotherapy Personalized medicine and pharmacogenomics Clinical drug evaluation Patient safety and sustained use of medicines.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信